Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ASH 2023 | Using single-cell RNA sequencing & proteomics to identify novel cell surface targets in AML

Name: Using single-cell RNA sequencing & proteomics to identify novel cell surface targets in AML
Uploaded: 2023-12-10T00:00:00Z
Duration: 57 s

Veronique Lisi • 10 Dec 2023

ASH 2023

Acute Myeloid Leukemia Leukemia Antibodies Gemtuzumab ozogamicin

In this video, Veronique Lisi, PhD, CHU Sainte-Justine Research Centre, Montreal, Canada, briefly discusses how single-cell RNA sequencing and proteomics are being used to identify novel therapeutic targets in acute myeloid leukemia (AML). This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.